SCHEMBL423795

SCHEMBL423795

[CH2]C1CCC(O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478967 1.00
SCHEMBL18894377 1.00
SCHEMBL2292339 0.79
SCHEMBL3389566 0.78 TSHR (0.64)
SCHEMBL28182 0.78
SCHEMBL1638758 0.78
SCHEMBL102859 0.78
SCHEMBL2700308 0.78 TSHR (0.64)
SCHEMBL1593359 0.78 TSHR (0.64)
SCHEMBL8036941 0.78 TSHR (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024012557-A1 ANTI-APOPTOTIC BCL-2 FAMILY PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BERRYBIO (HONG KONG) LIMITED (CN) 2024-01-18 WO claimed
CN-110358120-A A kind of preparation method and product of ultra-thin ultralow shrinking percentage graphene polyimides heat conducting film 江苏亚宝绝缘材料股份有限公司 2019-10-22 CN claimed
US-8466295-B2 Thiophene derivatives as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-06-18 US claimed
US-8455521-B2 Diaminoalkane aspartic protease inhibitors VITAE PHARMACEUTICALS, INC. (US) 2013-06-04 US claimed
US-20120270853-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-10-25 US claimed
US-8252830-B2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-08-28 US claimed
US-8163749-B2 Six-membered heterocycles useful as serine protease inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-24 US claimed
US-8106221-B2 Renin inhibitors VITAE PHARMACEUTICALS, INC. (US) 2012-01-31 US claimed
EP-1981854-B1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-06-01 EP claimed
CN-101072561-B Diaminoalkane aspartic protease inhibitors VITAE PHARMACEUTICALS INC 2011-05-11 CN claimed
EP-1157029-A1 OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY Pentapharm AG (CH) 2001-11-28 EP claimed
WO-2000050446-A1 OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY PENTAPHARM AG (CH) 2000-08-31 WO claimed
EP-0128118-B1 PEPTIDE DERIVATIVES AND THEIR USE AS SUBSTRATES IN THE QUANTITATIVE DETERMINATION OF ENZYMES Pentapharm A.G. (CH) 1991-08-14 EP claimed
US-4629695-A Peptide derivatives and use thereof as substrates for quantitatively assaying enzymes PENTAPHARM A.G. (CH) 1986-12-16 US claimed
EP-0078764-B1 PROCESS FOR THE QUANTITATIVE DETERMINATION OF THE BLOOD CLOTTING FACTOR XII IN HUMAN PLASMA Pentapharm A.G. (CH) 1986-01-02 EP claimed
US-4480030-A BLOOD-COAGULATION FACTOR XA PENTAPHARM A.G. (CH) 1984-10-30 US claimed
US-4440678-A ARGININES PENTAPHARM, A.G. (CH) 1984-04-03 US claimed
EP-0034122-B1 TRIPEPTIDE DERIVATIVES AND THEIR USE IN THE DETERMINATION OF ENZYMES Pentapharm A.G. (CH) 1983-09-21 EP claimed
WO-1981002294-A1 TRIPEPTIDIC DERIVATIVES AND USE THEREOF FOR ENZYME DETERMINATION PENTAPHARM AG (CH) 1981-08-20 WO claimed
EP-0034122-A1 Tripeptide derivatives and their use in the determination of enzymes Pentapharm A.G. (CH) 1981-08-19 EP claimed